Press release distribution, EDGAR filing, XBRL, regulatory filings

However the ARPU dropped slightly to $23.80 in 2013 from $24.10 in 2012. )--The acquisition of AstraZeneca Plc would achieve Pfizer, Inc.'s strategic aims as the deal promises significant benefits for the combined entity, according to Fitch ... )--FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT ... (more)

http://ift.tt/1m7vMc7